Due to the similarity in the structures of aurora kinases A and B, and a role for aurora kinase B in cancer progression and development of resistance, compound 2 was further evaluated for binding affinities for EGFR, AURKA and AURKB using a competition binding assay (DiscoverX Corporation, Fremont, CA, USA)5,.24 The gene discussed is AURKB; the disease is cancer.